LobbyingSyngenerx Health lobbying by quarter
Syngenerx Health's latest lobbying report covers Q2 2026, at $42.5K. Its first report covers Q1 2026; the issues it reports most are Medicare/Medicaid and Pharmacy.
Syngenerx Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $85K
- Last 3 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $42.5K | 1 |
| Q2 2026 | $42.5K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$42.5K · 2 reports
- Pharmacy$42.5K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)2 reports
- Health & Human Services, Dept of (HHS)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Armory Hill Advocates | $85K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/03for Q2 | Armory Hill Advocates | $42.5K |
| 05/18for Q1 | Armory Hill Advocates | $42.5K |
| 02/23for Q1 | Armory Hill Advocates | Under $5,000 |